Back to User profile » Professor Christopher E Brightling
Papers published by Professor Christopher E Brightling:
The Prognostic Value of Blood Eosinophil Level in AECOPD is Influenced by Corticosteroid Treatment During Hospitalization
Li J, Liang L, Feng L, Cao S, Cai YS, Li X, Qian Z, Brightling CE, Tong Z
Journal of Inflammation Research 2023, 16:3233-3243
Published Date: 2 August 2023
Sputum Streptococcus pneumoniae is reduced in COPD following treatment with benralizumab
George L, Wright A, Mistry V, Sutcliffe A, Chachi L, Haldar K, Ramsheh MY, Richardson M, van der Merwe R, Martin U, Newbold P, Brightling CE
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:1177-1185
Published Date: 5 June 2019
Sputum Moraxella catarrhalis strains exhibit diversity within and between COPD subjects
George LM, Haigh RD, Mistry V, Haldar K, Barer MR, Oggioni MR, Brightling CE
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3663-3667
Published Date: 8 November 2018
Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD
Thulborn SJ, Dilpazir M, Haldar K, Mistry V, Brightling CE, Barer MR, Bafadhel M
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1199-1205
Published Date: 18 April 2017
Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function
Bafadhel M, Haldar K, Barker B, Patel H, Mistry V, Barer MR, Pavord ID, Brightling CE
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1075-1083
Published Date: 9 June 2015
Systemic and pulmonary inflammation is independent of skeletal muscle changes in patients with chronic obstructive pulmonary disease
Barker BL, McKenna S, Mistry V, Pancholi M, Patel H, Haldar K, Barer MR, Pavord ID, Steiner MC, Brightling CE, Bafadhel M
International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:975-981
Published Date: 15 September 2014
Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial
Siva R, Bafadhel M, Monteiro W, Brightling CE, Pavord ID
International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:179-186
Published Date: 7 February 2014